Josh Hardy can return home to Fredericksburg
After nearly seven months at St. Jude Children’s Research Hospital in Memphis, Tenn., Josh Hardy is returning home to Fredericksburg.
His mother, Aimee, posted an update on her Facebook page and her Caringbridge site early Wednesday about his return.
His kidney function has returned and he no longer needs dialysis. His heart function is within normal range, his lung function is perfect and his tummy is coming around. He has not needed a blood transfusion in a month, Aimee writes.
She said with a lot of hard work, his strength will return. He’s able to walk a “nice distance” holding her hands and she anticipates the return of his immunity in a few months.
He won’t have to return to St. Jude until the end of July, and after that he’ll only have to go once per month until January.
The youngster attracted national attention earlier this year when he was gravely ill, battling cancer and an accompanying infection, and needed an experimental drug.
The deadly adenovirus has all but disappeared from his bloodstream after multiple doses of brincidofovir, a drug being developed by Chimerix Inc. of Raleigh, N.C.
Josh first took the drug March 12 and is now part of a new clinical trial.